What is AQST's current stock price?

As of now, AQST is trading at $5.72, with a daily change of +1.78%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

AQST Stock Analysis & IQ Rating | Aquestive Therapeutics

AQST

Aquestive Therapeutics

$5.72

+$0.10 | +1.78%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$7.55

MKT CAP

$697.86M

52W Low

$2.12

VOL

$2.00M

P/E Ratio

N/A

AVG VOL

$3.05M

RSI

45.52

TREND

Sideways

AQST Stock IQ

Login to see Aquestive Therapeutics (AQST) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

AQST Target Price

Login to display

Strengths

AQST Rewards

Earnings are forecast to grow

AQST Rewards

Upgraded on attractively valued

AQST Rewards

Trading below its fair value

AQST Rewards

Outperform the market

Chart

$6.72 (-14.88%)

$3.77 (+51.72%)

$3.72 (+53.76%)

$4.17 (+37.17%)

1year

6month

3month

1month

AQST Risk Level

AQST has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

AQST Analysts Opinion

AQST overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

AQST Analysts Opinion

AQST Analysts opinion is positive and also has improved from the past 3 months

AQST Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

89%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

AQST Street Sentiment

AQST Street Sentiment is extremely bullish and have positive views on the near-term outlook

AQST Performance Sentiment

Sentiments overview associated with AQST events and the stock performance.

89%

11%

Positive

Negative

8 out of 9
events present

1 out of 9
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$5.72

Resistance
Price

$4.91

Current Price Range

$7.34

Show methods +

Linked to AQST

IQ

Close Price

Change

REGN

4.20

755.90

+2.56%

NVS

4.27

127.31

+2.42%

AQST Latest Analysis +

Aquestive Therapeutics (AQST) Price Target Increased by 14.80% to 10.51. The average one-year price target for Aquestive Therapeutics (NasdaqGM:AQST) has been revised to $10.51 / share. This is an increase of 14.80% from the prior estimate of $9.15 dated November 7 2025. The price target is an average of many targets provided by a

Mon Nov 17, 2025

$5.82 | +7.98%

Potential

Jim Cramer: Joby Is Losing Too Much Money. On CNBC'.s “.Mad Money Lightning Round”. AQST) is a “.very interesting spec.”.Piper Sandler analyst David Amsellem on Nov. 7 maintained Aquestive Therapeutics with an Overweight rating and raised the price target from $5 to $8.APH) is such a “.great”. stock Cramer said. “.You want to stay ...

Wed Nov 12, 2025

$5.58 | -1.93%

Rating

Food Allergy Market Valued at USD 3 Billion across the 7MM Projected to Grow at CAGR of 11.3% by 2034 | DelveInsight. Food Allergy Market Valued at USD 3 Billion across the 7MM Projected to Grow at CAGR of 11.3% by 2034 |. DelveInsightThe food allergy market is expected to surge in the coming years primarily due to the adoption of recently approved therapies potential emerging therapies such as Viaskin (DBV712) Peanut Patch (DBV Technologies) PVX108 (Aravax) Remibrutinib (Novartis) SLIT tabl

Mon Nov 10, 2025

$5.58 | -7.62%

Activity

Momentum

Potential

Aquestive outlines Q1 2026 Anaphylm launch readiness and $44M-$50M revenue guidance while advancing Adrenaverse platform.

Thu Nov 6, 2025

$6.13 | +2.17%

Activity

Heres What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 Earnings. Although the revenue and EPS for Aquestive Therapeutics (AQST) give a sense of how its business performed in the quarter ended September 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Wed Nov 5, 2025

$6.00 | -1.32%

Potential

Aquestive Therapeutics GAAP EPS of -$0.14 misses by $0.01 revenue of $12.81M misses by $0.13M.

Wed Nov 5, 2025

$6.00 | -1.32%

Earnings

FAQ About AQST Stock Insights

What is AQST current stock price?

What are AQST stock strengths?

What is AQST Risk Level?

What is AQST market cap and volume?

What is AQST current Stock IQ?

Should I buy AQST stock right now?

Is AQST a Strong Buy right now?

What does a 'Strong Buy' rating mean for AQST?

What does a 'Strong Sell' rating mean for AQST?

What factors influence AQST's Stock IQ?

Explore our AQST Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored AQST Stock Strategies
Effective Risk Management

FIND US ON

Receive our AQST Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

AQST

Aquestive Therapeutics

Current Price

$5.72

+$0.10 | +1.78%

52W High

$7.55

MKT CAP

$697.86M

52W Low

$2.12

VOL

$2.00M

P/E Ratio

N/A

AVG VOL

$3.05M

RSI

45.52

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

AQST Rewards

Earnings are forecast to grow

AQST Rewards

Upgraded on attractively valued

AQST Rewards

Trading below its fair value

AQST Rewards

Outperform the market

Linked to AQST

Symbol

IQ

Close

Change

REGN

4.20

755.90

+2.56%

NVS

4.27

127.31

+2.42%

AQST Stock IQ

Login to unlock Aquestive Therapeutics (AQST) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$6.72 (-14.88%)

$3.77 (+51.72%)

$3.72 (+53.76%)

$4.17 (+37.17%)

1year

6month

3month

1month

AQST Analysts Opinion

AQST Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

AQST Analysts Opinion

AQST Analysts opinion is positive and also has improved from the past 3 months

AQST Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

89%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

AQST Street Sentiment

AQST Street Sentiment is extremely bullish and have positive views on the near-term outlook

AQST Risk Level

AQST has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

AQST Performance Sentiment

Sentiments overview associated with AQST events and the stock performance.

89%

11%

Positive

Negative

8 out of 9
events present

1 out of 9
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$5.72

Resistance
Price

$4.91

Current Price Range

$7.34

Show methods +

AQST Latest Analysis

Aquestive Therapeutics (AQST) Price Target Increased by 14.80% to 10.51. The average one-year price target for Aquestive Therapeutics (NasdaqGM:AQST) has been revised to $10.51 / share. This is an increase of 14.80% from the prior estimate of $9.15 dated November 7 2025. The price target is an average of many targets provided by a

Mon Nov 17, 2025

$5.82 | +7.98%

Potential

Jim Cramer: Joby Is Losing Too Much Money. On CNBC'.s “.Mad Money Lightning Round”. AQST) is a “.very interesting spec.”.Piper Sandler analyst David Amsellem on Nov. 7 maintained Aquestive Therapeutics with an Overweight rating and raised the price target from $5 to $8.APH) is such a “.great”. stock Cramer said. “.You want to stay ...

Wed Nov 12, 2025

$5.58 | -1.93%

Rating

Food Allergy Market Valued at USD 3 Billion across the 7MM Projected to Grow at CAGR of 11.3% by 2034 | DelveInsight. Food Allergy Market Valued at USD 3 Billion across the 7MM Projected to Grow at CAGR of 11.3% by 2034 |. DelveInsightThe food allergy market is expected to surge in the coming years primarily due to the adoption of recently approved therapies potential emerging therapies such as Viaskin (DBV712) Peanut Patch (DBV Technologies) PVX108 (Aravax) Remibrutinib (Novartis) SLIT tabl

Mon Nov 10, 2025

$5.58 | -7.62%

Activity

Momentum

Potential

Aquestive outlines Q1 2026 Anaphylm launch readiness and $44M-$50M revenue guidance while advancing Adrenaverse platform.

Thu Nov 6, 2025

$6.13 | +2.17%

Activity

Heres What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 Earnings. Although the revenue and EPS for Aquestive Therapeutics (AQST) give a sense of how its business performed in the quarter ended September 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Wed Nov 5, 2025

$6.00 | -1.32%

Potential

Aquestive Therapeutics GAAP EPS of -$0.14 misses by $0.01 revenue of $12.81M misses by $0.13M.

Wed Nov 5, 2025

$6.00 | -1.32%

Earnings

Discover AQST Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AQST. We're here to help you make informed investment decisions today.

FIND US ON

Receive our AQST Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AQST Stock trends

AQST Stock performance

AQST Stock analysis

AQST investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AQST

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AQST

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

AQST Stock Analysis & IQ Rating | Aquestive Therapeutics

AQST Stock IQ

AQST Target Price

AQST Risk Level

AQST Analysts Opinion

AQST Street Sentiment

AQST Performance Sentiment

Technical Price Levels

Explore our AQST Stock insights

Receive our AQST Daily Alerts

AQST Stock IQ

AQST Street Sentiment

AQST Risk Level

Technical Price Levels

Discover AQST Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AQST. We're here to help you make informed investment decisions today.

Receive our AQST Daily Alerts

AQST Runner Alarm